Regen BioPharma Inc (RGBP)

[art35]

OTCShotCaller
7/17/22, 07:07 PM
$RGBP
- For those interested, an in depth research of what new drug development cost from IP discovery (i.e. bench research) to commercialization is on a sliding scale from $43 Million to $2.9 Billion. Koos is far beyond bench research he conducted with his colleagues over the past 30+ years. The class of IP he has patents on cost anywhere from $78M to $160M to take through all 4 Phases of clinical trials, the average being about $120M
. These figures depend on multiple factors such as trial size of patient enrollment, duration of each phase, salaries of required personnel, liability insurance, and cost of the facility where the trial is conducted which can be in multiple locations, i.e. a "Multi-Center" Trial. Also the cost of clinical trials has risen significantly over the past several years. This gives you a rough idea of how much cash is required for him to advance just his current mRNA Vaccine IND into clinical trials, not including his other active IP. Thus his need for a B/O